Clinical Trials Browser

Muscle-invasive Bladder Urothelial Carcinoma × toripalimab × 1 year × Clear all

NCT07279597 2025-12-19

A Phase II Study of Toripalimab Plus RC48-ADC With Radiotherapy for Bladder Preservation in HER2-Positive Muscle-Invasive Bladder Cancer

Phase 2 Not yet recruiting

Muscle-invasive Bladder Urothelial Carcinoma